An advance in molecular imaging of dementias
- PMID: 17362826
- DOI: 10.1016/S1474-4422(07)70060-1
An advance in molecular imaging of dementias
Comment on
-
Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study.Lancet Neurol. 2007 Apr;6(4):305-13. doi: 10.1016/S1474-4422(07)70057-1. Lancet Neurol. 2007. PMID: 17362834 Clinical Trial.
Similar articles
-
Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies.Arch Neurol. 2004 Jun;61(6):919-25. doi: 10.1001/archneur.61.6.919. Arch Neurol. 2004. PMID: 15210531
-
[Nuclear medicine imaging in neurodegenerative dementias].Dtsch Med Wochenschr. 2008 May;133 Suppl 1:S5-7. doi: 10.1055/s-2008-1075678. Dtsch Med Wochenschr. 2008. PMID: 18437639 Review. German.
-
Imaging biomarkers and their role in dementia clinical trials.Can J Neurol Sci. 2007 Mar;34 Suppl 1:S77-83. doi: 10.1017/s031716710000562x. Can J Neurol Sci. 2007. PMID: 17469688 Review.
-
[DaT-SCAN SPECT in the differential diagnosis of dementia with Lewy bodies and Alzheimer's disease].Rev Neurol. 2005 Sep 1-15;41(5):276-9. Rev Neurol. 2005. PMID: 16138284 Spanish.
-
Neuroimaging as a diagnostic tool in dementia with Lewy bodies.Dement Geriatr Cogn Disord. 2004;17 Suppl 1:25-31. doi: 10.1159/000074679. Dement Geriatr Cogn Disord. 2004. PMID: 14676466 Review.
Cited by
-
Utility of 123I-FP-CIT SPECT for dementia diagnoses and therapeutic strategies in elderly patients.J Nutr Health Aging. 2014 Jan;18(1):50-3. doi: 10.1007/s12603-013-0346-7. J Nutr Health Aging. 2014. PMID: 24402389
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical